Dendreon Competitors and Similar CompaniesClear all
Dendreon's competitors and similar companies include Seagen, PIN Pharma, Aurora Biopharma and Affyimmune.
 Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. |  Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. |  PIN Pharma PIN Pharma is a biopharmaceutical company focused on developing broad-base immuno-modulatory therapies, linking the innate and adaptive immune systems. |  Affyimmune AffyImmune Therapeutics is a biotechnology company that focuses on cell-based immunotherapies for cancer. | ||
Founding Date | Founding Date 1992 | Founding Date 1998 | Founding Date 2011 | Founding Date N/A | Founding Date 2016 |
Type | Type Subsidiary | Type Subsidiary | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations New York, US HQ | Locations New York, US HQ | Locations Natick, US HQ Newton, US |
Employees | Employees 6131% decrease | Employees 3,25622% increase | Employees 1 | Employees 2 | Employees 4 |
For sources of this data, please see the company profile
View Company Profiles
Seagen
HQ
Bothell, US
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
View companyPIN Pharma
HQ
New York, US
Employees
1
PIN Pharma is a biopharmaceutical company focused on developing broad-base immuno-modulatory therapies, linking the innate and adaptive immune systems.
View company
Aurora Biopharma
HQ
New York, US
Employees
2
Aurora Biopharma is a company developing cancer immunotherapy.
View companyAffyimmune
HQ
Natick, US
Employees
4
AffyImmune Therapeutics is a biotechnology company that focuses on cell-based immunotherapies for cancer.
View company